Takeda Pharmaceutical Total Assets 2007-2019 | TAK

Takeda Pharmaceutical total assets from 2007 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Takeda Pharmaceutical total assets for the quarter ending September 30, 2019 were $119.785B, a 206.25% increase year-over-year.
  • Takeda Pharmaceutical total assets for 2019 were $124.851B, a 237.82% increase from 2018.
  • Takeda Pharmaceutical total assets for 2018 were $36.958B, a 8.77% decline from 2017.
  • Takeda Pharmaceutical total assets for 2017 were $40.509B, a 27.63% increase from 2016.
Takeda Pharmaceutical Annual Total Assets
(Millions of US $)
2019 $124,851
2018 $36,958
2017 $40,509
2016 $31,740
2015 $39,095
2014 $45,691
2013 $47,863
2012 $45,428
2011 $33,571
2010 $30,358
2009 $28,165
2008 $28,493
2007 $26,038
2006 $26,003
Takeda Pharmaceutical Quarterly Total Assets
(Millions of US $)
Q2 2019 $119,785
Q1 2019 $123,309
Q3 2018 $51,328
Q1 2018 $38,268
Q1 2017 $39,113
Q1 2016 $35,498
Q1 2015 $35,431
Q4 2015 $39,095
Q3 2014 $40,950
Q2 2014 $43,889
Q1 2014 $43,486
Q4 2014 $45,691
Q3 2013 $44,258
Q2 2013 $42,957
Q1 2013 $39,730
Q4 2013 $47,863
Q3 2012 $46,540
Q2 2012 $44,223
Q1 2012 $43,349
Q4 2012 $45,428
Q3 2011 $44,136
Q2 2011 $45,141
Q4 2011 $33,571
Q4 2010 $30,358
Q2 2009 $0
Q4 2009 $28,165
Q4 2008 $28,493
Q4 2007 $26,038
Q4 2006 $26,003
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $61.813B $18.875B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $64.924B 38.83
Astellas Pharma (ALPMY) Japan $32.875B 16.42
Eisai (ESALY) Japan $21.999B 42.41
Merck (MKGAF) Germany $16.989B 23.18
Grifols, S.A (GRFS) Spain $15.869B 20.79
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Neurocrine Biosciences (NBIX) United States $9.133B 431.17
Catalent (CTLT) United States $9.010B 36.65
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Ionis Pharmaceuticals (IONS) United States $8.358B 16.93
Jazz Pharmaceuticals (JAZZ) Ireland $8.245B 10.53
STADA ARZNEIMI (STDAF) Germany $5.972B 0.00
IPSEN SA ADR (IPSEY) France $5.862B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.540B 0.00
Hypermarcas (HYPMY) Brazil $5.282B 16.07
Arrowhead Pharmaceuticals (ARWR) United States $4.270B 64.65
Evotec AG (EVTCY) Germany $4.074B 65.85
United Therapeutics (UTHR) United States $3.920B 0.00
Nektar Therapeutics (NKTR) United States $3.717B 0.00
FibroGen (FGEN) United States $3.647B 107.18
Sage Therapeutics (SAGE) United States $3.525B 0.00
PTC Therapeutics (PTCT) United States $3.200B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.198B 11.77
ChemoCentryx (CCXI) United States $2.396B 0.00
Zogenix (ZGNX) United States $2.307B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.119B 0.00
Heron Therapeutics (HRTX) United States $2.035B 0.00
Tilray (TLRY) Canada $1.985B 0.00
Xencor (XNCR) United States $1.947B 59.19
Ironwood Pharmaceuticals (IRWD) United States $1.940B 61.85
Pacira Pharmaceuticals (PCRX) United States $1.828B 54.09
USANA Health Sciences (USNA) United States $1.608B 17.16
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
Corcept Therapeutics (CORT) United States $1.492B 18.13
Theravance Biopharma (TBPH) Cayman Islands $1.487B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.415B 9.65
Endo (ENDP) Ireland $1.343B 2.47
Enanta Pharmaceuticals (ENTA) United States $1.087B 24.71
Portola Pharmaceuticals (PTLA) United States $1.062B 0.00
Karyopharm Therapeutics (KPTI) United States $1.036B 0.00
Dermira (DERM) United States $1.020B 0.00
Aerie Pharmaceuticals (AERI) United States $0.996B 0.00
Akebia Therapeutics (AKBA) United States $0.943B 0.00
Radius Health (RDUS) United States $0.870B 0.00
Collegium Pharmaceutical (COLL) United States $0.702B 0.00
TherapeuticsMD (TXMD) United States $0.673B 0.00
Flexion Therapeutics (FLXN) United States $0.671B 0.00
ImmunoGen (IMGN) United States $0.659B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.547B 0.00
Molecular Templates (MTEM) United States $0.501B 0.00
Translate Bio (TBIO) United States $0.483B 0.00
Ardelyx (ARDX) United States $0.467B 0.00
Organogenesis Holdings (ORGO) United States $0.459B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.437B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.434B 0.00
Innate Pharma SA (IPHYF) France $0.432B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.422B 0.00
Siga Technologies (SIGA) United States $0.418B 9.56
BioCryst Pharmaceuticals (BCRX) United States $0.417B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.415B 17.91
Catalyst Pharmaceuticals (CPRX) United States $0.410B 49.75
DURECT (DRRX) United States $0.385B 0.00
OptiNose (OPTN) United States $0.371B 0.00
Calithera Biosciences (CALA) United States $0.363B 0.00
Recro Pharma (REPH) United States $0.361B 0.00
Lannett Co Inc (LCI) United States $0.361B 4.20
Harpoon Therapeutics (HARP) United States $0.360B 0.00
Rafael Holdings (RFL) United States $0.345B 0.00
Indivior (INVVY) United States $0.335B 1.21
KalVista Pharmaceuticals (KALV) United States $0.305B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.304B 0.00
Concert Pharmaceuticals (CNCE) United States $0.259B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.258B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.256B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.239B 0.00
MEI Pharma (MEIP) United States $0.237B 0.00
Ocular Therapeutix (OCUL) United States $0.217B 0.00
IMV INC (IMV) Canada $0.212B 0.00
Jounce Therapeutics (JNCE) United States $0.210B 2.80
La Jolla Pharmaceutical (LJPC) United States $0.206B 0.00
Nature's Sunshine Products (NATR) United States $0.193B 33.23
Taiwan Liposome (TLC) Taiwan $0.176B 0.00
Xeris Pharmaceuticals (XERS) United States $0.155B 0.00
CannTrust Holdings (CTST) Canada $0.150B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.139B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.139B 0.00
Redhill Biopharma (RDHL) Israel $0.131B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.121B 0.00
CV Sciences (CVSI) United States $0.116B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Otonomy (OTIC) United States $0.104B 0.00
Aquestive Therapeutics (AQST) United States $0.097B 0.00
Champions Oncology (CSBR) United States $0.096B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.095B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.094B 0.00
PolarityTE (PTE) United States $0.091B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.090B 0.00
Neos Therapeutics (NEOS) United States $0.088B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Infinity Pharmaceuticals (INFI) United States $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 22.73
CTI BioPharma (CTIC) United States $0.074B 0.00
RENEURON GP (RNUGF) United Kingdom $0.074B 0.00
AgeX Therapeutics (AGE) United States $0.067B 0.00
Aclaris Therapeutics (ACRS) United States $0.065B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.062B 15.39
Nivalis Therapeutics (ALPN) United States $0.061B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.00
IsoRay (ISR) United States $0.056B 0.00
Onconova Therapeutics (ONTX) United States $0.053B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.050B 0.00
Forward Pharma (FWP) Denmark $0.045B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.043B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
Jaguar Animal Health (JAGX) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Biomerica (BMRA) United States $0.030B 0.00
PharmAthene (ALT) United States $0.029B 0.00
India Globalization Capital (IGC) United States $0.026B 0.00
Regulus Therapeutics (RGLS) United States $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
VAXART, INC (VXRT) United States $0.024B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.020B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.019B 0.00
Novan (NOVN) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Shineco (TYHT) China $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Flex Pharma (SLRX) United States $0.012B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Vical (BBI) United States $0.011B 0.00
Heat Biologics (HTBX) United States $0.010B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00